Stay updated on Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial page
- Check6 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3. No visible changes to the study details or page functionality.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded revision label v3.4.2 and removed the prior operating-status notice (v3.4.1). No changes to the study details or outcomes.SummaryDifference0.4%

- Check41 days agoChange DetectedThe page now includes a government funding notice about operational status and a site revision update to v3.4.1 (from v3.4.0).SummaryDifference0.4%

- Check48 days agoChange DetectedThe page now shows a glossary, a 'Last Update Submitted that Met QC Criteria' indicator, a 'No FEAR Act Data' notice, and a revision badge 'Revision: v3.4.0'. The previously displayed items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 with no impact on study details or navigation; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedLocations section reorganized to consolidate site listings under a single Locations heading. Specific Japanese sites (Aichi-ken, Chiba, Fukuoka, Hokkaido, Ishikawa-ken, Kanagawa, Osaka, Tokyo) were added, and the former per-location headings (Aichi-ken Locations, Chiba Locations, etc.) were removed.SummaryDifference0.8%

Stay in the know with updates to Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial page.